… We have also made a lot of progress in advancing our innovation pipeline", said Daniel de Boer, Chief Executive … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expects up to four clinical data readouts in 2025 and 2026 across multi